Boston Research & Management’s Johnson & Johnson JNJ Stock Holding History

Boston Research & Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.44M	Hold	9,613	–	–	0.54%	62
2026 Q1	$2.35M	Hold	9,613	–	–	0.56%	60
2025 Q4	$1.99M	Hold	9,613	–	–	0.46%	62
2025 Q3	$1.78M	Sell	9,613 -48	-0.5%	-$8.22K	0.39%	62
2025 Q2	$1.48M	Hold	9,661	–	–	0.35%	63
2025 Q1	$1.6M	Hold	9,661	–	–	0.4%	61
2024 Q4	$1.4M	Hold	9,661	–	–	0.34%	66
2024 Q3	$1.56M	Sell	9,661 -50	-0.5%	-$7.97K	0.37%	65
2024 Q2	$1.42M	Hold	9,711	–	–	0.36%	67
2024 Q1	$1.54M	Hold	9,711	–	–	0.38%	65
2023 Q4	$1.52M	Hold	9,711	–	–	0.4%	64
2023 Q3	$1.51M	Sell	9,711 -62	-0.6%	-$10.2K	0.45%	65
2023 Q2	$1.62M	Hold	9,773	–	–	0.46%	64
2023 Q1	$1.51M	Sell	9,773 -22	-0.2%	-$3.55K	0.45%	63
2022 Q4	$1.73M	Buy	9,795 +22	+0.2%	+$3.8K	0.54%	62
2022 Q3	$1.6M	Hold	9,773	–	–	0.54%	62
2022 Q2	$1.73M	Hold	9,773	–	–	0.56%	64
2022 Q1	$1.73M	Buy	9,773 +200	+2%	+$34K	0.5%	63
2021 Q4	$1.64M	Hold	9,573	–	–	0.45%	64
2021 Q3	$1.55M	Hold	9,573	–	–	0.46%	63
2021 Q2	$1.58M	Hold	9,573	–	–	0.48%	62
2021 Q1	$1.57M	Hold	9,573	–	–	0.51%	61
2020 Q4	$1.51M	Sell	9,573 -129	-1%	-$19K	0.52%	58
2020 Q3	$1.44M	Hold	9,702	–	–	0.56%	56
2020 Q2	$1.36M	Buy	9,702 +177	+2%	+$25.8K	0.57%	55
2020 Q1	$1.25M	Buy	9,525 +50	+0.5%	+$7.09K	0.63%	51
2019 Q4	$1.38M	Hold	9,475	–	–	0.52%	55
2019 Q3	$1.23M	Hold	9,475	–	–	0.48%	56
2019 Q2	$1.32M	Buy	9,475 +120	+1%	+$16.6K	0.53%	53
2019 Q1	$1.31M	Hold	9,355	–	–	0.54%	53
2018 Q4	$1.21M	Hold	9,355	–	–	0.57%	52
2018 Q3	$1.29M	Hold	9,355	–	–	0.59%	54
2018 Q2	$1.14M	Hold	9,355	–	–	0.56%	56
2018 Q1	$1.2M	Sell	9,355 -450	-5%	-$60.8K	0.61%	53
2017 Q4	$1.37M	Sell	9,805 -700	-7%	-$97.5K	0.69%	53
2017 Q3	$1.36M	Hold	10,505	–	–	0.7%	53
2017 Q2	$1.39M	Hold	10,505	–	–	0.75%	52
2017 Q1	$1.31M	Hold	10,505	–	–	0.71%	54
2016 Q4	$1.21M	Buy	10,505 +115	+1%	+$13.3K	0.69%	55
2016 Q3	$1.23M	Hold	10,390	–	–	0.71%	54
2016 Q2	$1.26M	Hold	10,390	–	–	0.76%	52
2016 Q1	$1.12M	Hold	10,390	–	–	0.7%	55
2015 Q4	$1.07M	Sell	10,390 -2,200	-17%	-$221K	0.66%	55
2015 Q3	$1.18M	Hold	12,590	–	–	0.77%	55
2015 Q2	$1.23M	Sell	12,590 -250	-2%	-$25K	0.78%	52
2015 Q1	$1.29M	Hold	12,840	–	–	0.82%	50
2014 Q4	$1.34M	Buy	12,840 +1,500	+13%	+$158K	0.84%	50
2014 Q3	$1.21M	Hold	11,340	–	–	0.81%	54
2014 Q2	$1.19M	Buy	11,340 +700	+7%	+$70.8K	0.82%	54
2014 Q1	$1.04M	Hold	10,640	–	–	0.77%	53
2013 Q4	$974K	Hold	10,640	–	–	0.75%	53
2013 Q3	$922K	Hold	10,640	–	–	0.78%	52
2013 Q2	$913K	Buy	+10,640	New	+$903K	0.81%	52

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Boston Research & Management's JNJ Position: Q2 2026 in Review

Boston Research & Management held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 9,613 shares worth $2.44M. The position accounts for 0.54% of the portfolio, ranked #62.

Boston Research & Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Boston Research & Management held 9,613 shares of Johnson & Johnson worth $2.44M as of Q2 2026.
Boston Research & Management left its Johnson & Johnson share count unchanged in Q2 2026.
Johnson & Johnson made up 0.54% of Boston Research & Management's portfolio in Q2 2026, its #62 holding.
Boston Research & Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Boston Research & Management's 13F filing for Q2 2026, filed 11 Aug 2026.